Prostate Cancer Specification
0.1.0 - ci-build

Prostate Cancer Specification - Local Development build (v0.1.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions

: Inzidentelles Prostatakarzinom nach Enukleation - JSON Representation

Raw json | Download

{
  "resourceType" : "Condition",
  "id" : "TransurethralEnucleationDiagnosisPCa",
  "meta" : {
    "profile" : [
      🔗 "https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/StructureDefinition/mii-pr-onko-diagnose-primaertumor|2026.0.0"
    ]
  },
  "text" : {
    "status" : "extensions",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: Condition TransurethralEnucleationDiagnosisPCa</b></p><a name=\"TransurethralEnucleationDiagnosisPCa\"> </a><a name=\"hcTransurethralEnucleationDiagnosisPCa\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"https://simplifier.net/resolve?scope=de.medizininformatikinitiative.kerndatensatz.onkologie@2026.0.0&amp;canonical=https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/StructureDefinition/mii-pr-onko-diagnose-primaertumor\">MII PR Onkologie Diagnose Primärtumor</a> version: 2026.0.0</p></div><p><b>Condition Asserted Date</b>: 2024-02-20</p><p><b>clinicalStatus</b>: <span title=\"Codes:{http://terminology.hl7.org/CodeSystem/condition-clinical active}\">Active</span></p><p><b>verificationStatus</b>: <span title=\"Codes:{http://terminology.hl7.org/CodeSystem/condition-ver-status confirmed}\">Confirmed</span></p><p><b>category</b>: <span title=\"Codes:{http://terminology.hl7.org/CodeSystem/condition-category encounter-diagnosis}\">Encounter Diagnosis</span></p><p><b>code</b>: <span title=\"Codes:{http://fhir.de/CodeSystem/bfarm/icd-10-gm C61}\">Bösartige Neubildung der Prostata</span></p><p><b>subject</b>: <a href=\"Patient-Patient3.html\">Klaus Becker  Male, DoB: 1958-11-10 ( http://example.hospital.de/patient-ids#PAT-2024-003)</a></p><p><b>encounter</b>: <a href=\"Encounter-TransurethralEnucleationEncounter.html\">Encounter: identifier = http://example.hospital.de/encounters#E_24_004; status = finished; class = IMP (IMP)</a></p><p><b>onset</b>: 2024-02-20</p><p><b>recordedDate</b>: 2024-02-20</p><h3>Stages</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Summary</b></td><td><b>Type</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{http://snomed.info/sct 1222805004}\">IIIB (AJCC)</span></td><td><span title=\"Codes:{http://snomed.info/sct 260998006}\">Clinical staging (qualifier value)</span></td></tr></table><p><b>note</b>: </p><blockquote><div><p>Inzidentelles Prostatakarzinom ISUP Grade Group 5 (Gleason 4+5=9) mit ausgedehnter Infiltration, extraprostatischer Extension und Samenblaseninfiltration. Tumoranteil 60%. Klinisches Staging: cT3b cNx cMx. Hochrisiko-Karzinom, weitere Diagnostik und Therapieplanung erforderlich.</p>\n</div></blockquote></div>"
  },
  "extension" : [
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/condition-assertedDate",
      "valueDateTime" : "2024-02-20"
    }
  ],
  "clinicalStatus" : {
    "coding" : [
      {
        "system" : "http://terminology.hl7.org/CodeSystem/condition-clinical",
        "code" : "active"
      }
    ]
  },
  "verificationStatus" : {
    "coding" : [
      {
        "system" : "http://terminology.hl7.org/CodeSystem/condition-ver-status",
        "code" : "confirmed"
      }
    ]
  },
  "category" : [
    {
      "coding" : [
        {
          "system" : "http://terminology.hl7.org/CodeSystem/condition-category",
          "code" : "encounter-diagnosis"
        }
      ]
    }
  ],
  "code" : {
    "coding" : [
      {
        "system" : "http://fhir.de/CodeSystem/bfarm/icd-10-gm",
        "version" : "2026",
        "code" : "C61",
        "display" : "Bösartige Neubildung der Prostata"
      }
    ]
  },
  "subject" : {
    🔗 "reference" : "Patient/Patient3"
  },
  "encounter" : {
    🔗 "reference" : "Encounter/TransurethralEnucleationEncounter"
  },
  "onsetDateTime" : "2024-02-20",
  "recordedDate" : "2024-02-20",
  "stage" : [
    {
      "summary" : {
        "coding" : [
          {
            "system" : "http://snomed.info/sct",
            "code" : "1222805004",
            "display" : "IIIB (AJCC)"
          }
        ]
      },
      "type" : {
        "coding" : [
          {
            "system" : "http://snomed.info/sct",
            "code" : "260998006",
            "display" : "Clinical staging (qualifier value)"
          }
        ]
      }
    }
  ],
  "note" : [
    {
      "text" : "Inzidentelles Prostatakarzinom ISUP Grade Group 5 (Gleason 4+5=9) mit ausgedehnter Infiltration, extraprostatischer Extension und Samenblaseninfiltration. Tumoranteil 60%. Klinisches Staging: cT3b cNx cMx. Hochrisiko-Karzinom, weitere Diagnostik und Therapieplanung erforderlich."
    }
  ]
}